SK74693A3 - Beta-phenylisoserine-(2r, 3s), salts, preparation and use thereof - Google Patents
Beta-phenylisoserine-(2r, 3s), salts, preparation and use thereof Download PDFInfo
- Publication number
- SK74693A3 SK74693A3 SK746-93A SK74693A SK74693A3 SK 74693 A3 SK74693 A3 SK 74693A3 SK 74693 A SK74693 A SK 74693A SK 74693 A3 SK74693 A3 SK 74693A3
- Authority
- SK
- Slovakia
- Prior art keywords
- beta
- salt
- ammonium
- salts
- ammonia
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epoxy Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cephalosporin Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
Description
Oblasť technikyTechnical field
Vynález sa týka (2R , 3S)-beta-feny1 i zošer inu vzorca I :The present invention relates to (2R, 3S) -beta-phenyl and to the compounds of formula I:
COOHCOOH
(I) jeho soli s alkalickými kovmi, s kovmi alkalických zemín a s dusíkatými zásadami, spôsobu jeho prípravy a jeho použitia pre prípravu terapeutických účinných látok.(I) its alkali metal, alkaline earth metal and nitrogen base salts, process for its preparation and its use for the preparation of therapeutic active substances.
Doterajší stav technikyBACKGROUND OF THE INVENTION
Zatiaľ čo izoméry (2R,3R), (2S,3S) a (2S,3R) beta-fenylizoserínu sú z vedeckej literatúry známe, napríklad z článkov E.Kamandi-ho a kol. v Arch.Pharmaz., 307,871-878(1974), E. Kamandi-ho a kol. v Árch.Pharmaz., 308,135-141(1975) alebo K.Harada-a a Y.Nakajima-a v Bull.Chem.Soc.Japan,47,2911-2912 (1974), nebol (2R,3S)-beta-fenylizoserín až doposiaľ popísaný inak ako vo forme esteru /H.Hon i g a kol., Tetrahedron, 46(11) 3841-3850(1990)/.While the (2R, 3R), (2S, 3S) and (2S, 3R) beta-phenylisoserine isomers are known in the scientific literature, for example, the articles of E. Kamandi et al. in Arch.Pharmaz., 307, 871-878 (1974), E. Kamandi et al. in Pharm. Pharm., 308, 135-141 (1975) or K. Harada and Y. Nakajima in Bull.Chem.Soc.Japan, 47, 2911-2912 (1974), or (2R, 3S) -beta. Phenylisoserine to date described so far other than in the form of the ester (H.H. iga et al., Tetrahedron, 46 (11) 3841-3850 (1990)).
Podstata vynálezuSUMMARY OF THE INVENTION
Podľa vynálezu sa môže (2R,3S)-beta-fenylizoserín, prípadne vo forme soli, získať pôsobením amoniaku na kyselinu (2R,3R)-beta-feny 1 g 1ycidovú, výhodne vo forme soli s alkalickým kovom alebo kovom alkalických zemín (sodná, draselná alebo vápenatá soľ), amónne soli alebo soli s dusíkatou zásadou (alfa-metyl-benzylamín, pyridín).According to the invention, (2R, 3S) -beta-phenylisoserine, optionally in the form of a salt, can be obtained by treating ammonia with (2R, 3R) -beta-phenyl 1 g of 1-acid, preferably in the form of an alkali metal or alkaline earth metal salt. , potassium or calcium salt), ammonium or nitrogen base salts (alpha-methylbenzylamine, pyridine).
Obvykle sa táto reakcia uskutočňuje vo vode, prípadne v zmesi s organickým rozpúšťadlom, akým je metanol. Výhodne sa uvedená reakcia uskutočňuje vo vode.Typically, this reaction is carried out in water, optionally in admixture with an organic solvent such as methanol. Preferably, said reaction is carried out in water.
Pri spôsobe podľa vynálezu je nevyhnutné použiť prebytok amoniaku vzhľadom ku kyseline (2R,3R)-beta-feny 1 g 1 y cidovej. Obvykle sa použije 10 až 100 molov amoniaku, výhodne 50 až 80 molov amoniaku na jeden mól kyseliny (2R,3R)-beta-fenylglycidovej.In the process according to the invention, it is necessary to use an excess of ammonia with respect to (2R, 3R) -beta-phenyl 1 g of 1-ylic acid. Usually 10 to 100 moles of ammonia, preferably 50 to 80 moles of ammonia, are used per mole of (2R, 3R) -beta-phenylglycidic acid.
Amoniak sa výhodne použije vo forme koncentrovaného vodného roztoku, akým je roztok, ktorého koncentrácia sa pri teplote blízkej 25°C pohybuje v rozmedzí 20 až 32 % hmotnosť i .The ammonia is preferably used in the form of a concentrated aqueous solution, such as a solution having a concentration in the range of 20 to 32% by weight i.
Spôsob podľa vynálezu sa uskutočňuje pri teplote 0 až 100°C, výhodne pri teplote 40 až 60°C. Obvykle sa pracuje za atmosférického tlaku alebo tiež pri autogénnom tlaku, ktorý sa pri teplote 60°C rovná asi 0,25 MPa.The process according to the invention is carried out at a temperature of 0 to 100 ° C, preferably at a temperature of 40 to 60 ° C. Usually, the process is carried out at atmospheric pressure or else at an autogenous pressure, which at 60 [deg.] C. equals about 5 bar.
Za účelom urýchlenia reakcie je obzvlášť výhodne pracovať v prítomnosti amónnej soli, akou je^ chlorid amónny alebo hydrogénuh1 i č itan amónny. Výhodné je použiť hydrogénuhličitan amónny, ktorý umožňuje zvýšiť reakčnú rýchlosť pri zachovaní selektivity reakcie. Obvykle sa použije stechiometrické množstvo uvedenej amónnej soli vzhľadom k použitému množstvu kyseliny beta-feny1 g 1ycidovej.In order to accelerate the reaction, it is particularly advantageous to work in the presence of an ammonium salt such as ammonium chloride or ammonium bicarbonate. It is preferred to use ammonium bicarbonate which allows to increase the reaction rate while maintaining the selectivity of the reaction. Usually, a stoichiometric amount of said ammonium salt relative to the amount of beta-phenyl acid used is used.
Spôsob podľa vynálezu sa obvykle uskutočňuje pri použití soli kyseliny (2R,3R )-beta-feny1 g 1ycidovej s a 1 fa-mety 1 benzy1amínom.The process according to the invention is usually carried out using (2R, 3R) -beta-phenylglycidic acid salt and 1-methylbenzylamine.
Je však možné takisto použiť soľ alkalického kovu (sodná soľ, draselná soľ), ktorá sa získa pôsobením zásady (hydroxid sodný, hy d r ox i d draselný) v stechiometrickom množstve na soľ kyseliny (2R,3R)-beta-fenylglycidovej s alfametylbenzylamínom, alebo amónnu soľ, ktorá sa získa pôsobením prebytku amoniaku na soľ kyseliny (2R,3R)-beta-fenylglycidovej s alfa-metylbenzy lamínom. V tomto poslednom uvedenom prípade je možné priaznivo ovplyvniť priebeh reakcie kontinuálnou alebo sem i kontinuálnou extrakciou alfa-metylbenzylamínu vhodným organickým rozpúšťadlom, akým je toluén.However, it is also possible to use an alkali metal salt (sodium salt, potassium salt) which is obtained by treating the (2R, 3R) -beta-phenylglycidic acid salt with alpha-methylbenzylamine by stoichiometric treatment with a base (sodium hydroxide, potassium hydroxide), or ammonium salt, which is obtained by treating excess (2R, 3R) -beta-phenylglycidic acid with alpha-methylbenzylamine with an excess of ammonia. In the latter case, the course of the reaction can be favorably influenced by continuous or semi-continuous extraction of alpha-methylbenzylamine with a suitable organic solvent, such as toluene.
Obzvlášť zaujímavé je použiť amónnu soľ kyseliny (2R,3R)-beta-fenylglycidovej, ktorá umožňuje otvorenie kruhu amoniakom, ktoré je regioselektívne a stereoselektívne.Of particular interest is the use of the ammonium salt of (2R, 3R) -beta-phenylglycidic acid, which allows ring opening by ammonia, which is regioselective and stereoselective.
Bez ohľadu na to, akým spôsobom sa pôsobí amoniakom na kyselinu (2R,3R )-beta-feny1 g 1ycidovú, sa môže (2R,3S)-betafeny1 i zošer í n izolovať jednou z nasledujúcich metód :Regardless of how (2R, 3R) -beta-phenylglycidic acid is treated with ammonia, (2R, 3S) -betaphenyl may be isolated by one of the following methods:
1) Prebytok amoniaku sa môže odohnať za zníženého tlaku tak, aby sa získal vodný roztok amónnej soli kyseliny (2R,3S)-beta-feny1 g 1ycidovej. Po pridaní silnej minerálnej kyseliny sa vyzráža (2R,3S)-beta-fenylizoserín, ktorý sa oddelí filtráciou, alebo1) Excess ammonia can be removed under reduced pressure to obtain an aqueous ammonium salt of (2R, 3S) -beta-phenylglycidic acid. Upon addition of a strong mineral acid, (2R, 3S) -beta-phenylisoserine precipitates which is separated by filtration, or
2) pred, v priebehu alebo po odstránení amoniaku za zníženého tlaku je možné prida.ť zásadu alkalického kovu (hydroxid sodný alebo hydroxid draselný) alebo kovu alkalických zemín (oxid vápenatý, hydroxid vápenatý); vytvorená soľ sa vyzráža po prípadnom pridaní organického rozpúšťadla, akým je acetón. Takto získaná soľ alkalického kovu alebo kovu alkalických zemín sa oddelí filtráciou. Za účelom ľahšieho vysolenia soli, obzvlášť sodnej soli (2R,3S)-beta-feny1 i zošer ínu, a zlepšenia výťažku sa môže výhodne nasýtiť voda prítomná v reakčnej zmesi pridaním chloridu sodného.2) alkali metal (sodium hydroxide or potassium hydroxide) or alkaline earth metal (calcium oxide, calcium hydroxide) may be added before, during or after removal of ammonia under reduced pressure; the salt formed precipitates upon optional addition of an organic solvent such as acetone. The alkali metal or alkaline earth metal salt thus obtained is separated by filtration. In order to facilitate the salting out of the salt, especially the sodium salt of (2R, 3S) -beta-phenylcarboline, and to improve the yield, it is advantageous to saturate the water present in the reaction mixture by adding sodium chloride.
Uvedená kyselina (2R,3R)-beta-feny 1 g 1 ycidová sa môže pripraviť za podmienok popísaných J-N.Deriis-om a kol. v J.Org.Chem.,51,46-50(1986).Said (2R, 3R) -beta-phenyl-1-gacidic acid may be prepared under the conditions described by J-N.Deriis et al. Chem., 51, 46-50 (1986).
(2R,3S)-beta-fenylizoserín získaný spôsobom podľa vynálezu je obzvlášť vhodný zlúčenín, akými účinnýchThe (2R, 3S) -beta-phenylisoserine obtained by the process according to the invention is particularly suitable as active compounds.
C0-0-sú deriváty pre syntézu terapeuticky taxánu všeobecného vzorcaCO-O-are derivatives for the synthesis of a therapeutically taxane of formula
v ktorom R znamená atóm znamená fenylovu-skúpinu vodíka alebo acetylovú skupinu a R -> alebo terc.butoxy-skupinu.wherein R represents an atom represents a phenyl group of hydrogen or an acetyl group and R => or a tert-butoxy group.
Pôsobením benzoy1ačného činidla (benzoy1 ch 1 or i d) alebo terc.butoxyka.rbonylačného činidla (terc.butyldikarbonát) a potom činidla pre ochranu hydroxy-funkcie sa z beta-feny1 i zo serínu získa zlúčenina všeobecného vzorca III :By treatment with a benzoylating agent (benzoyl chloride) or a tert-butoxycarbonylating agent (tert-butyl dicarbonate) and then a hydroxy-protecting agent, a compound of formula III is obtained from beta-phenyl and serine:
RjCO-NHRJCO-NH
COOH (III) v ktorom Ri znamená fenylovú skupinu alebo terc.butoxy-skupinu a Zi znamená ochrannú skupinu hydroxylovej funkcie (1-etoxyety1ová skupina) .COOH (III) wherein R 1 represents a phenyl group or a tert-butoxy group and Z 1 represents a hydroxyl function protecting group (1-ethoxyethyl).
Kondenzáciou kyseliny všeobecného vzorca III s b a c c a t i nom III alebo 10-deacety1baccatinom III, ktorého hydroxyfunkcie v polohe 7 a prípadne v polohe 10 sú chránené ochrannými skupinami (silylované skupiny, 2,2,2,-tri ch 1óretoxykarbonylová skupina) a následným nahradením uvedených ochranných skupín atómami vodíka sa získa produkt všeobecného vzorca II.Condensation of an acid of formula III with saccharin III or 10-deacetylbaccatin III, whose hydroxyfunction at position 7 and optionally at position 10 are protected by protecting groups (silylated groups, 2,2,2, -trichloroethoxycarbonyl group) and subsequent replacement of said protecting groups hydrogen atoms to give the product of formula II.
Uvedená kondenzácia kyseliny všeobecného vzorca III s baccatinom III alebo s 1 0-deacety1baccatinom III, chráneným uvedeným spôsobom, ako aj nahradenie ochranných skupín atómami vodíka sa môže vykonať za podmienok, popísaných v európskych patentoch EP-0 336 840 alebo EP-0 336 841.Said condensation of an acid of formula III with baccatin III or with 10-deacetylbaccatin III protected as described above, as well as the replacement of the protecting groups with hydrogen atoms can be carried out under the conditions described in European patents EP-0 336 840 or EP-0 336 841.
V nasledujúcej časti popisu bude vynález bližšie objasnený pomocou príkladov jeho konkrétneho uskutočnenia, ktoré však majú iba ilustračný charakter a nijako neobmedzujú rozsah vynálezu, ktorý je jednoznačne vymedzený formuláciou patentových nárokov.In the following, the invention will be further elucidated by means of examples of specific embodiments thereof, which, however, are provided by way of illustration only and are not intended to limit the scope of the invention as defined by the claims.
Príklady uskutočnenia vynálezuDETAILED DESCRIPTION OF THE INVENTION
Príklad 1Example 1
Do kolóny sa zavedú 3 kg alfa-metylbenzylamín-(2R,3R)beta-feny1 g 1ycidátu, ktorého čistota je 98 % a ktorý má enantiomérny prebytok vyšší ako 98,5 % , a 15 litrov 32 % (hm./hm.) amoniaku. Do päty kolóny sa pomocou dávkovacieho čerpadla zavedie toluén v množstve 3 až 5 litrov za hodinu. Toluénový roztok sa v hlave kolóny odstraňuje prietokom. Po zavedení 18 litrov toluénu už nie je možné v tomto toluénovom extrakte zistiť prítomnosť a 1 fa-mety1benzy1amínu.3 kg of alpha-methylbenzylamine (2R, 3R) beta-phenylglycidate having a purity of 98% and having an enantiomeric excess of greater than 98.5% and 15 liters of 32% (w / w) are loaded onto the column. ammonia. Toluene at a rate of 3-5 liters per hour is fed to the bottom of the column. The toluene solution is removed at the top of the column by flow. After the introduction of 18 liters of toluene, the presence of α 1 -methylbenzylamine can no longer be detected in this toluene extract.
Do autoklávu o obsahu 150 litrov sa zavedie vyššie uvedeným spôsobom získan.ý roztok beta-f eny 1 g 1 yc i dátu amónneho a 30 litrov 32 % (hm./hm.) amoniaku. Autokláv sa uzavrie a jeho obsah sa zohrieva po dobu jednej hodiny za miešania na teplotu 60°C. Tlak v autokláve činí asi 0,25 MPa. V miešaní sa potom pokračuje pri teplote 60°C ešte po dobu 5 hodín, a potom sa reakčná zmes nechá vychladnúť na teplotu 18°C. Amoniak sa odoženie destiláciou za zníženého tlaku (13,3 až 93 kPa) pri teplote 24°C po predchádzajúcom pridaní 9 kg chloridu sodného a 0,42 kg kôstkového hydroxidu sodného v 2,5 litroch vody. Keď tlak v autokláve dosiahne 6 kPa, zohreje sa reakčná zmes na teplotu 48°C za účelom rozpustenia solí, a potom sa chladí na teplotu -5 až -8°C po dobu 3 hodín.A solution of beta-phenyl 1 g of ammonium nitrate and 30 liters of 32% (w / w) ammonia was introduced into the 150-liter autoclave as described above. The autoclave is sealed and heated to 60 ° C with stirring for one hour. The pressure in the autoclave is about 0.25 MPa. Stirring was then continued at 60 ° C for 5 hours and then allowed to cool to 18 ° C. The ammonia is removed by distillation under reduced pressure (13.3 to 93 kPa) at 24 ° C after the previous addition of 9 kg of sodium chloride and 0.42 kg of lime sodium hydroxide in 2.5 liters of water. When the pressure in the autoclave reaches 6 kPa, the reaction mixture is heated to 48 ° C to dissolve the salts, and then cooled to -5 to -8 ° C for 3 hours.
Získané biele kryštál e. sa oddelia filtráciou a potom sa vysušia pri teplote 40°C za zníženého tlaku (0,13 kPa). Týmto spôsobom sa získa 1932 g sodnej soli (2R,3S)-beta-fenylizo serínu topiaceho sa pri teplote 218°C.White crystal obtained e. The mixture is separated by filtration and then dried at 40 ° C under reduced pressure (0.13 kPa). In this way, 1932 g of (2R, 3S) -beta-phenyl-iso-serine sodium salt melting at 218 ° C is obtained.
13C-nuk leárne magnet íckorezonančné spektrum sodnej soli (2R,3S)-beta-feny 1 i zošer ínu, stanovené v ťažkej vode pri 90 MHz, je charakterizované nasledujúcimi chemickými posunmi delta : 13 The C-Nuclear Magnetic Resonance Spectrum of (2R, 3S) -beta-phenylene iodine sodium, determined in heavy water at 90 MHz, is characterized by the following delta chemical shifts:
60,2 (1JCH=140 Hz ) ;60.2 ( 1 JCH = 140 Hz);
80,0 (1JCH =147 Hz; 2J = 2,6 Hz) ;80.0 ( 1 JCH = 147Hz; 2 J = 2.6Hz);
129,6; 131,5; 144,4 a 181,6 ppm.129.6; 131.5; 144.4 and 181.6 ppm.
P r í k 1 a d 2Example 1 a d 2
Do reaktora o obsahu 250 litrov sa zavedie 10 kg alfamety1benzy1amin-(2R,3R)-beta-feny1 g 1 yc idátu ( 35,08 molu), 15 litrov vody a 20 litrov toluénu, a potom sa v priebehu 10 minút pridá 10 litrov 4N hydroxidu sodného o teplote blízkej 20°C. Zmes sa mieša po dobu jednej hodiny. Vodná fáza sa oddelí dekantáciou. Toluénová fáza, ktorá obsahuje alfa-metylbenzylamín, sa zachová pre ďalšie spracovanie. Vodná fáza sa dvakrát premyje 10 litrami toluénu za účelom úplného odstránenia alfa-metylbenzylamínu. Zo zlúčených toluénových fáz sa môže potom izolovať a 1 fa-mety1benzy1amin.10 kg of alpha-methylbenzylamine- (2R, 3R) -beta-phenyl 1 g of cyanate (35.08 mol), 15 liters of water and 20 liters of toluene are introduced into a 250-liter reactor and then 10 liters are added over 10 minutes. 4N sodium hydroxide at a temperature close to 20 ° C. The mixture was stirred for one hour. The aqueous phase is separated by decantation. The toluene phase containing alpha-methylbenzylamine is retained for further processing. The aqueous phase is washed twice with 10 liters of toluene to completely remove the alpha-methylbenzylamine. The α-methylbenzylamine can then be isolated from the combined toluene phases.
K vodnej fáze, zavedenej do 250 litrového reaktora sa pridá 1,860 kg chloridu amónneho a 162 litrov 20 % (hm./obj.) amoniaku. Zmes sa zohreje na teplotu 50°C a pri tejto teplote sa za miešania udržuje po dobu 17 hodín. Po ochladení na 35°C sa pridá 35 kg chloridu sodného a zmes sa udržuje pri tejto teplote po dobu 30 minút. Reakčná zmes sa potom pozvoľne (v priebehu 2 hodín) nechá vychladnúť na teplotu 0 až 5°C a pri tejto teplote sa udržuje po dobu jednej hodiny. Vylúčená zrazenina sa oddelí filtráciou a potom vysuší za zníženého tlaku pri teplote 50°C. Týmto spôsobom sa získa 7 kg suchého produktu, ktorý obsahuje asi 25 % chloridu sodného a asi1.860 kg of ammonium chloride and 162 liters of 20% (w / v) ammonia are added to the aqueous phase introduced into the 250-liter reactor. The mixture was heated to 50 ° C and maintained at this temperature for 17 hours with stirring. After cooling to 35 ° C, 35 kg of sodium chloride are added and the mixture is maintained at this temperature for 30 minutes. The reaction mixture is then slowly (over 2 hours) allowed to cool to 0-5 ° C and maintained at this temperature for one hour. The precipitate formed is collected by filtration and then dried under reduced pressure at 50 ° C. In this way, 7 kg of dry product are obtained which contains about 25% sodium chloride and about
5,300 kg sodnej soli čistého (2R,3S)-beta-fenyl izošer ínu.5.300 kg of pure (2R, 3S) -beta-phenyl isosine sodium.
Výťažok sa rovná 72 %.Yield 72%.
Takto získaná zlúčenina sa môže použiť ako taká, pri reakčných stupňoch nasledujúcich syntéz.The compound thus obtained can be used as such in the reaction steps of the following syntheses.
Claims (6)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9100491A FR2671799B1 (en) | 1991-01-17 | 1991-01-17 | B-PHENYLISOSERINE- (2R, 3S), ITS SALTS, ITS PREPARATION AND ITS USE. |
PCT/FR1992/000032 WO1992012958A1 (en) | 1991-01-17 | 1992-01-16 | β-PHENYLISOSERINE-(2R,3S), SALTS, PREPARATION AND USE THEREOF |
Publications (2)
Publication Number | Publication Date |
---|---|
SK74693A3 true SK74693A3 (en) | 1994-03-09 |
SK281140B6 SK281140B6 (en) | 2000-12-11 |
Family
ID=9408773
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK746-93A SK281140B6 (en) | 1991-01-17 | 1992-01-16 | (2r,3s)-beta-phenylisoserine and its salts and their preparation and use |
Country Status (25)
Country | Link |
---|---|
EP (2) | EP0603176B2 (en) |
JP (1) | JP3233632B2 (en) |
KR (1) | KR100235372B1 (en) |
AT (1) | ATE157081T1 (en) |
AU (1) | AU651669B2 (en) |
CA (1) | CA2099783C (en) |
CZ (1) | CZ281266B6 (en) |
DE (1) | DE69221733T3 (en) |
DK (1) | DK0603176T4 (en) |
ES (1) | ES2104895T5 (en) |
FI (1) | FI113641B (en) |
FR (1) | FR2671799B1 (en) |
GR (1) | GR3024533T3 (en) |
HU (1) | HU213616B (en) |
IE (1) | IE920127A1 (en) |
MX (1) | MX9200181A (en) |
NO (1) | NO303539B1 (en) |
NZ (1) | NZ241312A (en) |
PL (1) | PL167676B1 (en) |
RU (1) | RU2090551C1 (en) |
SK (1) | SK281140B6 (en) |
TW (1) | TW221413B (en) |
WO (1) | WO1992012958A1 (en) |
YU (1) | YU48153B (en) |
ZA (1) | ZA92317B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5646176A (en) | 1992-12-24 | 1997-07-08 | Bristol-Myers Squibb Company | Phosphonooxymethyl ethers of taxane derivatives |
TW467896B (en) * | 1993-03-19 | 2001-12-11 | Bristol Myers Squibb Co | Novel β-lactams, methods for the preparation of taxanes and sidechain-bearing taxanes |
WO2003047508A2 (en) | 2001-11-30 | 2003-06-12 | Bristol-Myers Squibb Company | Paclitaxel solvates |
US20200005163A1 (en) | 2017-02-10 | 2020-01-02 | Nec Corporation | Inference-use knowledge generation apparatus, inference-use knowledge generation method, and computer-readable recording medium |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2629818B1 (en) † | 1988-04-06 | 1990-11-16 | Centre Nat Rech Scient | PROCESS FOR THE PREPARATION OF TAXOL |
FR2629819B1 (en) † | 1988-04-06 | 1990-11-16 | Rhone Poulenc Sante | PROCESS FOR THE PREPARATION OF BACCATIN III AND DESACETYL-10 BACCATIN III DERIVATIVES |
CA2023645C (en) † | 1989-08-23 | 2002-03-26 | Jean-Noel Denis | Process for the enantioselective preparation of phenylisoserin derivatives |
-
1991
- 1991-01-17 FR FR9100491A patent/FR2671799B1/en not_active Expired - Lifetime
-
1992
- 1992-01-15 NZ NZ241312A patent/NZ241312A/en not_active IP Right Cessation
- 1992-01-16 AU AU12237/92A patent/AU651669B2/en not_active Expired
- 1992-01-16 EP EP92904034A patent/EP0603176B2/en not_active Expired - Lifetime
- 1992-01-16 ES ES92904034T patent/ES2104895T5/en not_active Expired - Lifetime
- 1992-01-16 TW TW081100266A patent/TW221413B/zh not_active IP Right Cessation
- 1992-01-16 JP JP50400792A patent/JP3233632B2/en not_active Expired - Fee Related
- 1992-01-16 AT AT92904034T patent/ATE157081T1/en not_active IP Right Cessation
- 1992-01-16 CA CA002099783A patent/CA2099783C/en not_active Expired - Lifetime
- 1992-01-16 WO PCT/FR1992/000032 patent/WO1992012958A1/en active IP Right Grant
- 1992-01-16 HU HU9302064A patent/HU213616B/en unknown
- 1992-01-16 IE IE012792A patent/IE920127A1/en not_active IP Right Cessation
- 1992-01-16 PL PL92299833A patent/PL167676B1/en unknown
- 1992-01-16 EP EP92400112A patent/EP0495718A1/en active Pending
- 1992-01-16 SK SK746-93A patent/SK281140B6/en not_active IP Right Cessation
- 1992-01-16 DK DK92904034T patent/DK0603176T4/en active
- 1992-01-16 KR KR1019930702148A patent/KR100235372B1/en not_active IP Right Cessation
- 1992-01-16 CZ CS931390A patent/CZ281266B6/en not_active IP Right Cessation
- 1992-01-16 ZA ZA92317A patent/ZA92317B/en unknown
- 1992-01-16 DE DE69221733T patent/DE69221733T3/en not_active Expired - Lifetime
- 1992-01-16 MX MX9200181A patent/MX9200181A/en active IP Right Grant
- 1992-01-16 RU RU9293051781A patent/RU2090551C1/en active
- 1992-01-17 YU YU5492A patent/YU48153B/en unknown
-
1993
- 1993-07-06 NO NO932458A patent/NO303539B1/en not_active IP Right Cessation
- 1993-07-16 FI FI933249A patent/FI113641B/en active
-
1997
- 1997-08-26 GR GR960402650T patent/GR3024533T3/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20070185336A1 (en) | Process for preparing n-protected 4-ketoproline derivatives | |
IE922234A1 (en) | Process for the preparation of derivatives of baccatin III and of 10-deacetylbaccatin III | |
CA2205745C (en) | Method for the preparation of baccatin iii and derivatives thereof from 10-deacetylbaccatin iii | |
JPH06234715A (en) | Production of alanylglutamine | |
SK74693A3 (en) | Beta-phenylisoserine-(2r, 3s), salts, preparation and use thereof | |
HU209615B (en) | Process for preparing derivatives of beta-phenylisoserine | |
US5684168A (en) | β-phenylisoserine-(2R,3S), salts, preparation and use thereof | |
EP0769003B1 (en) | Amino acid-derived diaminopropanols | |
JP3719318B2 (en) | Process for producing 1-ethyl-5-hydroxypyrazole | |
RU98122366A (en) | IMPROVED METHOD OF LACTONIZATION IN OBTAINING STATINS | |
JP3285440B2 (en) | Method for producing N-alkoxycarbonyl amino acid ester | |
US6320072B1 (en) | Method for isolation of n-protected s-phenylcysteine | |
JP2953553B2 (en) | Method for producing N-alkoxycarbonyl amino acid ester | |
FR2669031A1 (en) | PROCESS FOR THE PREPARATION OF TETRAHYDROPYRANE DERIVATIVES. | |
JP2000186069A (en) | Isolation of n-protected-s-phenylcysteine | |
JPH08208530A (en) | Removal of phthaloyl group from phthalimide | |
JPS61129177A (en) | Production of epoxysuccinic acid monoester derivative | |
HU217978B (en) | Process for producing taxane derivatives with using (2r,3s)-betha-phenyl-isoserine | |
CZ20003887A3 (en) | Isolation process of N-protected-S-phenylcysteine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK4A | Patent expired |
Expiry date: 20120116 |